Skip to main content

Typhoid Vaccine Recalled

An estimated 700,000 people immunized against typhoid may not be fully protected.

Written byEdyta Zielinska
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

Salmonella enterica (serovar typhimurium)Centers for Disease Control and PreventionThe typhoid vaccine called Typhim Vi made by Sanofi Pasteur was recalled this week (October 8), due to insufficient potency in 88 percent of its stock. Anyone immunized after January 2011 could have received the weaker vaccine that may not protect against infection, reported BBC News.

Typhoid fever, in which patients can experience sustained temperatures of 103 degrees Fahrenheit or higher, as well as stomach pains and rose-colored spots, is caused by the bacterium Salmonella Typhi. The disease is not common in the United Kingdom or the United States, but it still causes 21 million infections per year in the developing world. Visitors to South or South East Asia commonly get the vaccine prior to travel, and the U.K.’s Medicines and Healthcare products Regulatory Agency said that travelers returning from those areas should be vigilant for signs of disease, and contact a doctor immediately if symptoms appear.

"There are no concerns over the safety of this vaccine, but the recall has taken place because the vaccine may not be as effective ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • The Scientist Placeholder Image

    Edyta Zielinska was a senior editor at The Scientist from 2007 to 2013, where she worked closely with scientific illustrators to develop accompanying graphics to illuminate complex concepts. 

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo